Dr. Milrod is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
72 E Concord St
Boston, MA 02118Phone+1 617-638-6500
Education & Training
Boston University Medical CenterResidency, Internal Medicine, 2019 - 2022
Drexel University College of MedicineClass of 2019
Certifications & Licensure
RI State Medical License 2022 - 2025
MA State Medical License 2019 - 2022- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Progression-free survival is a weakly predictive surrogate end-point for overall survival in follicular lymphoma: A systematic review and meta-analysis.Charles J Milrod, Kang Woo Kim, Christina Raker, Thomas A Ollila, Adam J Olszewski
British Journal of Haematology. 2024-06-01 - Immune checkpoint inhibitors in advanced and relapsed/refractory Hodgkin lymphoma: current applications and future prospects.Charles J Milrod, Ari Pelcovits, Thomas A Ollila
Frontiers in Oncology. 2024-01-01 - Pancytopenia associated with bone marrow infiltration from late relapse of neuroblastoma.Charles J Milrod, Geoffrey Binney, Muhammad Azeem Khan
The Lancet. Oncology. 2023-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
